Biocogniv Closes $6M in Seed Funding Led By Breyer Capital to Advance Digital Diagnostic Platform
Summary
Biocogniv closed a $6M rolling seed round led by Breyer Capital with participation from Y Combinator, 1984 Ventures, Inflect Health, Promus Ventures, The Fund at Hula, and several angel investors. The company will use the funds to further develop and validate its aiMarkers predictive AI models and its clinOS real-time, cloud-based platform that deploys those models into clinical care. Several new investors and advisors, including Myla Lai-Goldman, Leo Grady, and Jonathan Hirsch, are joining Biocogniv's advisory board. Biocogniv's software is already connected to multiple U.S. hospital systems and focuses on predicting time-critical conditions such as sepsis using laboratory data and AI.
Funding
Amount
$6.0M
Total raised
Date
March 16, 2022
Announcement date
Investors
LabCorp, 1984 Ventures, Boston Scientific, Y Combinator, Inflect Health, Promus Ventures, IBM, Breyer Capital
Lead investors
Company
biocogniv.com
Funded company
Classifications
industries
HealthTech
applications
AI & Machine learning
AskAI Classifications
Labels
Healthcare Software
AI Diagnostics
Medical Software
Linked Companies
Biocogniv
$1M to $5M